SOX4 and colorectal cancer: This ultimately promotes SOX4‐mediated epithelial–mesenchymal transition and activates the SOX4‐driven PI3K/Akt signaling pathway, enhancing colorectal cancer development.[21] Erasers like FTO and ALKBH5 remove these modifications, thereby reversing the effects of writers and influencing RNA processes.[22]